Endovia Health Sciences (EDVA) Non-Current Assets (2013 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Non-Current Assets (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 5.15 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 294.93 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 1.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 18.06 Bn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 175,925.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 175,925.00 |
| Mar 31, 2026 | 61,105.00 |
| Dec 31, 2025 | 333,701.00 |
| Sep 30, 2025 | 20.52 Mn |
| Jun 30, 2025 | 20.63 Mn |
| Mar 31, 2025 | 813,885.00 |
| Dec 31, 2024 | 855,066.00 |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Sep 30, 2023 | 6.13 Mn |
| Jun 30, 2023 | 6.24 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 6.65 Mn |
| Sep 30, 2022 | 7.25 Mn |
| Jun 30, 2022 | 7.40 Mn |
| Mar 31, 2022 | 7.71 Mn |
| Dec 31, 2021 | 8.04 Mn |
| Sep 30, 2021 | 8.12 Mn |